nimbolide has been researched along with Invasiveness, Neoplasm in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, H; Liu, C; Qiu, S; Sun, S; Xie, L | 1 |
| Cabang, AB; Morris, J; Mukhopadhyay, KD; Patel, MJ; Tripathy, S; Wangjam, T; Wargovich, MJ | 1 |
| Kumar, GH; Manikandan, P; Nagini, S; Priyadarsini, RV | 1 |
| Babykutty, S; Gopala, S; J, NR; Kumar, MA; Nair, MS; S, PP; Srinivas, P | 1 |
4 other study(ies) available for nimbolide and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling.
Topics: A549 Cells; Azadirachta; Carcinoma, Non-Small-Cell Lung; Cell Movement; Dose-Response Relationship, Drug; Dual-Specificity Phosphatases; Gene Expression Regulation, Neoplastic; Humans; Limonins; Lung Neoplasms; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Phosphatases; Neoplasm Invasiveness | 2017 |
A supercritical CO
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Azadirachta; Carbon Dioxide; Cell Movement; Cell Proliferation; Colonic Neoplasms; HCT116 Cells; HT29 Cells; Humans; Inflammation; Limonins; Mice; Neoplasm Invasiveness; Plant Extracts | 2018 |
The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobiotic-metabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antioxidants; Base Sequence; Cheek; Cricetinae; DNA Damage; DNA Primers; Enzymes; Free Radical Scavengers; In Vitro Techniques; Limonins; Male; Mesocricetus; Mouth Mucosa; Neoplasm Invasiveness; Neoplasms, Experimental; Neovascularization, Pathologic; Xenobiotics | 2009 |
Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-κB in colon cancer cells.
Topics: Antineoplastic Agents; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Cyclin A; Cyclin D1; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Limonins; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Promoter Regions, Genetic; RNA, Messenger; Vascular Endothelial Growth Factor A | 2012 |